company background image
GSK logo

GSK BASE:GSK Stock Report

Last Price

AR$11.62k

Market Cap

AR$74.2t

7D

1.8%

1Y

236.8%

Updated

25 Mar, 2024

Data

Company Financials +

GSK Stock Overview

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health3/6
Dividends4/6

GSK plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GSK
Historical stock prices
Current Share PriceUK£11,616.00
52 Week HighUK£13,585.00
52 Week LowUK£3,404.50
Beta0.26
1 Month Change-0.22%
3 Month Change39.46%
1 Year Change236.84%
3 Year Change597.66%
5 Year Changen/a
Change since IPO63,332.08%

Recent News & Updates

Recent updates

Shareholder Returns

GSKAR PharmaceuticalsAR Market
7D1.8%0.8%13.2%
1Y236.8%-9.2%439.8%

Return vs Industry: GSK exceeded the AR Pharmaceuticals industry which returned -9.2% over the past year.

Return vs Market: GSK underperformed the AR Market which returned 439.8% over the past year.

Price Volatility

Is GSK's price volatile compared to industry and market?
GSK volatility
GSK Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement10.3%
10% most volatile stocks in AR Market16.0%
10% least volatile stocks in AR Market7.9%

Stable Share Price: GSK's share price has been volatile over the past 3 months.

Volatility Over Time: GSK's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
171570,212Emma Walmsleyhttps://www.gsk.com

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines.

GSK plc Fundamentals Summary

How do GSK's earnings and revenue compare to its market cap?
GSK fundamental statistics
Market capAR$74.19t
Earnings (TTM)AR$5.30t
Revenue (TTM)AR$32.65t

14.0x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GSK income statement (TTM)
RevenueUK£30.33b
Cost of RevenueUK£8.39b
Gross ProfitUK£21.94b
Other ExpensesUK£17.01b
EarningsUK£4.93b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 01, 2024

Earnings per share (EPS)1.21
Gross Margin72.34%
Net Profit Margin16.25%
Debt/Equity Ratio131.4%

How did GSK perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

48%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.